Tyra Biosciences, Inc. (TYRA) Financials
TYRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 225.9 million | 21.6 million |
2023-09-30 | 238.4 million | 16.2 million |
2023-06-30 | 250.0 million | 11.4 million |
2023-03-31 | -101.3 million | 2.3 million |
TYRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.1 million | 4.2 million |
2023-09-30 | -17.2 million | 4.4 million |
2023-06-30 | -9.7 million | 2.5 million |
2023-03-31 | -9.9 million | 2.4 million |
TYRA Net Income
No data available :(
TYRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 6.5 million |
2023-09-30 | 215.7 million | - | 6.1 million |
2023-06-30 | 232.4 million | - | 6.1 million |
2023-03-31 | 241.7 million | - | 2.6 million |
TYRA Shares Outstanding
TYRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 603000 | 20.7 million | 5.0 million | - |
2023-09-30 | 83000 | 19.3 million | 4.7 million | - |
2023-06-30 | 43000 | 12.2 million | 3.9 million | - |
2023-03-31 | 41000 | 10.4 million | 3.9 million | - |
TYRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 82000 |
2023-06-30 | - | 86000 |
2023-03-31 | - | 83000 |
TYRA
Price: $15.67
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -13.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1674
Market Capitalization: 945.4 million